Sign in

CIK 0001885522 · Non-accelerated filer<br>Smaller reporting company

Neumora Therapeutics, Inc.

Sign in to watch
Ticker
NMRA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
844367680
Phone
(857) 760-0900
Business address
260 ARSENAL PLACE, SUITE 1, WATERTOWN, MA, 02472
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$481,506
in 2 filings

Net −$481,506. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Aurora Daljit Singh −$482K See Remarks sold 100% of stake
Date Insider Transaction Shares Price Value Owned after
2025-05-28 Aurora Daljit Singh See Remarks Grant or award · Stock Option (Right to Buy) +40,890 40,890
2025-05-28 Aurora Daljit Singh See Remarks Grant or award · Stock Option (Right to Buy) +137,538 137,538
2025-05-28 Aurora Daljit Singh See Remarks Grant or award · Stock Option (Right to Buy) +207,901 207,901
2025-05-28 Aurora Daljit Singh See Remarks Grant or award · Stock Option (Right to Buy) +136,210 136,210
2025-05-28 Aurora Daljit Singh See Remarks Grant or award · Stock Option (Right to Buy) +72,221 72,221
2025-05-28 Aurora Daljit Singh See Remarks Grant or award · Stock Option (Right to Buy) +29,737 29,737
2025-05-28 Aurora Daljit Singh See Remarks Grant or award · Stock Option (Right to Buy) +195,000 195,000
2025-05-28 Aurora Daljit Singh See Remarks Grant or award · Stock Option (Right to Buy) +1,000,000 1,000,000
2025-05-28 Piacquad David Director Returned to the company · Stock Option (Right to Buy) −46,455 0
2025-05-28 Piacquad David Director Returned to the company · Stock Option (Right to Buy) −28,571 0
2025-05-28 Piacquad David Director Grant or award · Stock Option (Right to Buy) +46,455 46,455
2025-05-28 Piacquad David Director Grant or award · Stock Option (Right to Buy) +28,571 28,571
2025-05-28 Piacquad David Director Grant or award · Stock Option (Right to Buy) +80,000 80,000
2025-05-28 BERNS PAUL L See Remarks Returned to the company · Stock Option (Right to Buy) −497,049 0
2025-05-28 BERNS PAUL L See Remarks Returned to the company · Stock Option (Right to Buy) −955,864 0
2025-05-28 BERNS PAUL L See Remarks Returned to the company · Stock Option (Right to Buy) −342,500 0
2025-05-28 BERNS PAUL L See Remarks Returned to the company · Stock Option (Right to Buy) −2,000,000 0
2025-05-28 BERNS PAUL L See Remarks Grant or award · Stock Option (Right to Buy) +497,049 497,049
2025-05-28 BERNS PAUL L See Remarks Grant or award · Stock Option (Right to Buy) +955,864 955,864
2025-05-28 BERNS PAUL L See Remarks Grant or award · Stock Option (Right to Buy) +342,500 342,500

Page 6 of 20 · 384 trades